World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
50697
World Ranking
12425
National Ranking
6361

Overview

Jerry P. Palmer is affiliated with the University of Washington in the United States and has contributed extensively to research in the fields of medicine, biochemistry, genetics, and molecular biology. Their work predominantly focuses on endocrinology, diabetes, and metabolism, with significant attention given to pancreatic function and diabetes management.

The main topics covered in their research output include:

  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Immune Cell Function and Interaction
  • Blood Pressure and Hypertension Studies

Jerry P. Palmer's frequent co-authors reflect collaborations with established researchers in the field, including:

  • Steven E. Kahn
  • Kieren J. Mather
  • Kristina M. Utzschneider
  • Kristen J. Nadeau
  • Jay M. Sosenko

The scholar has published primarily in venues that focus on diabetes and metabolic research. Most publications appear in:

  • Diabetes Care
  • Diabetes
  • Diabetologia
  • Journal of Clinical Investigation
  • Endocrine Reviews

Among recent papers authored or co-authored by Jerry P. Palmer are:

  • Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia, 2021, Journal of Clinical Investigation
  • Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count, 2021, Endocrine Reviews
  • Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study, 2021, Diabetes Care
  • OGTT Glucose Response Curves, Insulin Sensitivity, and β-Cell Function in RISE: Comparison Between Youth and Adults at Randomization and in Response to Interventions to Preserve β-Cell Function, 2021, Diabetes Care
  • Differential loss of β-cell function in youth vs. adults following treatment withdrawal in the Restoring Insulin Secretion (RISE) study, 2021, Diabetes Research and Clinical Practice

The research primarily addresses key issues in diabetes pathophysiology, including pancreatic β-cell function, glycemic control, and factors influencing disease progression in both youth and adults.

Jerry P. Palmer has also contributed to knowledge on the genetic and molecular basis of diabetes, synthesizing insights into immune cell function and the complex interactions influencing metabolic health.

Their body of work has emphasized multiple subfields within medicine such as surgery, genetics, and immunology, reflecting a comprehensive approach to diabetes and metabolic disorders research.

Best Publications

  • Report of the expert committee on the diagnosis and classification of diabetes mellitus

    James R. Gavin;K. G M M Alberti;Mayer B. Davidson;Ralph A. DeFronzo

  • Follow-up report on the diagnosis of diabetes mellitus.

    Saul Genuth;K. G M M Alberti;Peter Bennett;John Buse

  • Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

    S E Kahn;R L Prigeon;D K McCulloch;E J Boyko

  • Insulin antibodies in insulin-dependent diabetics before insulin treatment

    Jerry P. Palmer;Christopher M. Asplin;Peter Clemons;Kenneth Lyen

  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

    Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow

  • Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

    Skyler Js;Krischer Jp;Wolfsdorf J;Cowie C

  • Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

    Donna J. Koerker;Willy Ruch;Elliott Chideckel;Jerry Palmer

  • C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21–22 October 2001

    Jerry P. Palmer;G. Alexander Fleming;Carla J. Greenbaum;Kevan C. Herold

  • Latent autoimmune diabetes in adults (LADA) should be less latent.

    S Fourlanos;F Dotta;C J Greenbaum;J P Palmer

  • Aspirin Effects on Mortality and Morbidity in Patients With Diabetes Mellitus: Early Treatment Diabetic Retinopathy Study Report 14

    Aaron Kassoff;Sheldon M. Buzney;J. Wallace McMeel;John J. Weiter

  • Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and complications trial

    Neil H. White;Wanjie Sun;Patricia A. Cleary;Ronald P. Danis

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus

    Johnny Ludvigsson;David Krisky;Rosaura Casas;Tadej Battelino

  • Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys

    Charles J. Goodner;Barbara C. Walike;Donna J. Koerker;John W. Ensinck

  • Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children.

    William A. Hagopian;Carani B. Sanjeevi;Ingrid Kockum;Mona Landin-Olsson

  • Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes TrialNet data

    C. J. Greenbaum;C. A. Beam;D. Boulware;S. E. Gitelman

  • Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

    Tihamer Orban;Jay M. Sosenko;David Cuthbertson;Jeffrey P. Krischer

  • A novel micro-assay for insulin autoantibodies.

    Alistair J.K. Williams;Polly J. Bingley;Ezio Bonifacio;Jerry P. Palmer

  • Genetic Effects on Age-Dependent Onset and Islet Cell Autoantibody Markers in Type 1 Diabetes

    Jinko Graham;William A. Hagopian;Ingrid Kockum;Lou Sheng Li

  • Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

    J P Palmer;J W Benson;R M Walter;J W Ensinck

Frequent Co-Authors

Jay S. Skyler
Jay S. Skyler University of Miami
Carla J. Greenbaum
Carla J. Greenbaum Virginia Mason Medical Center
Jeffrey P. Krischer
Jeffrey P. Krischer University of South Florida
Kevan C. Herold
Kevan C. Herold Yale University
Åke Lernmark
Åke Lernmark Lund University
John M. Lachin
John M. Lachin George Washington University
Dorothy J. Becker
Dorothy J. Becker University of Pittsburgh
Desmond A. Schatz
Desmond A. Schatz University of Florida
Steven E. Kahn
Steven E. Kahn University of Washington
George S. Eisenbarth
George S. Eisenbarth University of Colorado Denver

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or complementary educational options, several online degrees and career pathways are available. These programs can help launch or advance careers in healthcare beyond the traditional MD or DO route.

Many professionals pursue cheap online dnp programs, which offer flexibility and affordability for nurses aiming for leadership or advanced practice roles. Similarly, pharmacists can enhance their education with pharm d online programs, often designed to accommodate working professionals.

For those interested in health technology, a degree in health informatics opens doors to careers in managing digital health records and health data security. Meanwhile, students looking for entry-level healthcare roles can consider affordable medical billing and coding programs that are quick to complete and highly in demand.

Exploring these online degrees can provide flexible, cost-effective ways to enter or enhance your role in the growing healthcare sector.

Best Scientists Citing Jerry P. Palmer

Trending Scientists